O
A icon

OrbiMed’s Agilent Technologies A Stock Holding History

OrbiMed’s Portfolio A Stock Details A Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-893,200
Closed -$66.7M – 117
2019
Q2 		$66.7M Buy
893,200
+94,500
+12% +$7M 1.03% 33
2019
Q1 		$64.2M Buy
798,700
+45,700
+6% +$3.47M 0.99% 31
2018
Q4 		$50.8M Sell
753,000
-332,100
-31% -$22.3M 0.94% 36
2018
Q3 		$76.5M Sell
1,085,100
-800,000
-42% -$52.9M 0.92% 29
2018
Q2 		$117M Sell
1,885,100
-951,800
-34% -$62.1M 1.39% 24
2018
Q1 		$190M Buy
2,836,900
+246,200
+10% +$17.3M 2.35% 10
2017
Q4 		$173M Sell
2,590,700
-1,048,200
-29% -$70.7M 2.19% 13
2017
Q3 		$234M Sell
3,638,900
-175,200
-5% -$10.9M 2.23% 12
2017
Q2 		$226M Buy
3,814,100
+184,200
+5% +$10.5M 2.37% 10
2017
Q1 		$192M Hold
3,629,900
– – 2.18% 11
2016
Q4 		$165M Sell
3,629,900
-84,900
-2% -$3.85M 2.11% 14
2016
Q3 		$175M Buy
3,714,800
+149,600
+4% +$6.98M 1.99% 12
2016
Q2 		$158M Buy
3,565,200
+70,200
+2% +$3.03M 1.65% 20
2016
Q1 		$139M Buy
3,495,000
+169,000
+5% +$6.44M 1.47% 23
2015
Q4 		$139M Sell
3,326,000
-213,000
-6% -$8.24M 1.26% 26
2015
Q3 		$121M Sell
3,539,000
-129,000
-4% -$4.88M 1.23% 26
2015
Q2 		$142M Sell
3,668,000
-383,000
-9% -$15.9M 1.18% 28
2015
Q1 		$168M Hold
4,051,000
– – 1.44% 26
2014
Q4 		$166M Sell
4,051,000
-1,959,002
-33% -$79M 1.58% 25
2014
Q3 		$175M Buy
6,010,002
+1,633,843
+37% +$66.7M 1.83% 19
2014
Q2 		$180M Buy
4,376,159
+122,604
+3% +$4.92M 2.11% 18
2014
Q1 		$170M Buy
4,253,555
+34,950
+0.8% +$1.44M 2.09% 15
2013
Q4 		$173M Buy
4,218,605
+1,078,697
+34% +$41M 2.54% 14
2013
Q3 		$115M Buy
3,139,908
+548,016
+21% +$18.5M 2.05% 16
2013
Q2 		$79.3M Buy
+2,591,892
New +$80.5M 1.68% 21

Other funds holding A

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

OrbiMed's A Position: Q3 2019 in Review

OrbiMed sold out of Agilent Technologies (A) in Q3 2019, closing a stake of 893,200 shares — an estimated $66.7M sold.

OrbiMed first reported a position in A in Q2 2013 and held it in 25 quarters. The position peaked at $234M in Q3 2017. 700 funds tracked by Wall St. Rank hold A as of Q3 2019.

  • OrbiMed reported no remaining Agilent Technologies position as of Q3 2019 after selling out during the quarter.
  • OrbiMed sold 893,200 Agilent Technologies shares in Q3 2019, an estimated $66.7M.
  • OrbiMed first reported a position in Agilent Technologies in Q2 2013 and held it in 25 quarters.
  • OrbiMed's Agilent Technologies position peaked at $234M in Q3 2017.
  • 700 funds tracked by Wall St. Rank held Agilent Technologies as of Q3 2019.

Based on OrbiMed's 13F filing for Q3 2019, filed 14 Nov 2019.